Dashboard
Manage Tickers

OVIDOvid Therapeutics Inc.

Nasdaq ovidrx.com


$ 0.74 $ -0.01 (-1.72 %)    

Friday, 05-Jul-2024 11:03:18 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 493.73 $ 1.99 (0.4 %)
DIA $ 392.84 $ 0.01 (0 %)
SPY $ 552.32 $ 0.53 (0.1 %)
TLT $ 92.37 $ 0.29 (0.31 %)
GLD $ 220.29 $ 2.30 (1.06 %)
$ 0.7517
$ 0.76
$ 0.00 x 0
$ 0.75 x 200
$ 0.74 - $ 0.76
$ 0.68 - $ 4.14
336,114
na
53.16M
$ 0.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 03-13-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-07-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-29-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 06-13-2017 03-31-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-ovid-therapeutics-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Ovid...
07/02/2024 10:23:50

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Ovid Therapeutics (NASDAQ:OVID) with a Buy and maintains $3 pr...

ovid-therapeutics-and-graviton-bioscience-announces-topline-data-from-phase-1-clinical-trial-studying-ov888gv101-capsule-for-cerebral-cavernous-malformations
Ovid Therapeutics And Graviton Bioscience ...
07/01/2024 12:03:48

The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no ...

btig-maintains-buy-on-ovid-therapeutics-lowers-price-target-to-5
BTIG Maintains Buy on Ovid Therapeutics, L...
06/18/2024 16:56:29

BTIG analyst Thomas Shrader maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and lowers the price target from $11 to $5.

b-riley-securities-maintains-buy-on-ovid-therapeutics-lowers-price-target-to-3
B. Riley Securities Maintains Buy on Ovid ...
06/18/2024 15:10:44

B. Riley Securities analyst Kalpit Patel maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and lowers the price target fr...

citigroup-maintains-neutral-on-ovid-therapeutics-lowers-price-target-to-12
Citigroup Maintains Neutral on Ovid Therap...
06/18/2024 14:44:28

Citigroup analyst Yigal Nochomovitz maintains Ovid Therapeutics (NASDAQ:OVID) with a Neutral and lowers the price target fro...

evaluating-ovid-therapeutics-insights-from-6-financial-analysts
Evaluating Ovid Therapeutics: Insights Fro...
06/18/2024 13:00:43

hc-wainwright--co-maintains-buy-on-ovid-therapeutics-lowers-price-target-to-3
HC Wainwright & Co. Maintains Buy on Ovid ...
06/18/2024 12:20:01

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and lowers the price...

nasdaq-surges-over-200-points-aarons-shares-jump
Nasdaq Surges Over 200 Points; Aaron's Sha...
06/17/2024 18:40:51

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

crude-oil-rises-1-mustang-bio-shares-spike-higher
Crude Oil Rises 1%; Mustang Bio Shares Spi...
06/17/2024 16:16:09

us-stocks-mixed-dow-tumbles-over-100-points
US Stocks Mixed; Dow Tumbles Over 100 Points
06/17/2024 13:40:41

whats-going-on-with-ovid-therapeutics-after-takedas-two-phase-3-epilepsy-studies-fail
What's Going On With Ovid Therapeutics Aft...
06/17/2024 12:58:59

Takeda Pharmaceutical reveals Phase 3 study data for Soticlestat (TAK-935) in treating Dravet and Lennox-Gastaut syndromes. In ...

why-nurix-therapeutics-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why Nurix Therapeutics Shares Are Trading ...
06/17/2024 12:43:16

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
06/17/2024 12:07:49

Core News & Articles
After Takeda's Phase 3 Topline Study Resul...
06/17/2024 11:01:02

Core News & Articles
Takeda Announced Topline Data From SKYLINE...
06/17/2024 10:48:35

SKYLINE Study in Dravet Syndrome Narrowly Missed its Primary Endpoint of Reduction in Convulsive Seizure Frequency and Showed ...

hc-wainwright--co-reiterates-buy-on-ovid-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Ovid...
05/16/2024 11:07:06

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Ovid Therapeutics (NASDAQ:OVID) with a Buy and maintains $9 pr...

ovid-therapeutics-q1-eps-017-beats-021-estimate-sales-14800k-beat-5000k-estimate
Ovid Therapeutics Q1 EPS $(0.17) Beats $(0...
05/14/2024 12:19:53

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0...

cracking-the-code-understanding-analyst-reviews-for-ovid-therapeutics
Cracking The Code: Understanding Analyst R...
05/07/2024 19:00:38

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)